CLK4 Antibodies

Santa Cruz Biotechnology provides a broad selection of CLK4 monoclonal antibodies for investigating CLK4 in cellular processes. The monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CLK4, or cyclin-dependent kinase 4, is a crucial regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. CLK4 activity is essential for proper cell proliferation and differentiation, making it a significant target in cancer research and therapeutic development. Dysregulation of CLK4 has been implicated in various malignancies, highlighting its importance in maintaining cellular homeostasis. CLK4 monoclonal antibodies enable precise detection and quantification of CLK4 expression levels across different experimental conditions. Researchers can utilize CLK4 monoclonal antibodies to examine protein-protein interactions and cellular localization patterns. Understanding CLK4's role in cell cycle regulation continues to reveal new insights into cancer biology and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CLK4 support researchers worldwide in advancing our understanding of cell cycle regulation and cancer biology.